E O Okoro
Index: J. Pharm. Pharmacol. 51 , 953, (1999)
Full Text: HTML
We have previously shown that elimination of buffer Ca2+ markedly reduced maximum 5-HT-induced contractions. We have now investigated the effect of L-type Ca2+-channel blockers and 5-HT2 receptor antagonists on 5-HT- and K+-induced contractions in rat aorta to explore the possibility of a relationship between blockade of L-type Ca2+ channels and 5-HT2 receptor antagonism. Sodium nitroprusside, felodipine, nifedipine, diltiazem, cinnarizine, verapamil, ritanserin, cyproheptadine, ketanserin and mianserin inhibited 5-HT-induced contractions of rat aorta with mean IC50 values (concentration (M) resulting in 50% inhibition) of 2.2 x 10(-11), 6.6 x 10(-11), 1.5 x 10(-9), 1.7 x 10(-9), 3.2 x 10(-7), 5.4 x 10(-7), 9.7 x 10(-10), 1.9 x 10(-8), 5.0 x 10(-7) and 6.4 x 10(-7), respectively. The same compounds antagonized K+-induced rat aortic contractions with the rank order of potency (mean IC50, M): felodipine (7.0 x 10(-11)) > nifedipine (4.8 x 10(-9)) > sodium nitroprusside (4.1 x 10(-8)) > verapamil (5.5 x 10(-8)) > cyproheptadine (6.2 x 10(-8)) > diltiazem (4.1 x 10(-7)) > cinnarizine (1.3 x 10(-6)) > ritanserin (1.8 x 10(-6)) > ketanserin (9.0 x 10(-6)) > mianserin (2.0 x 10(-5)). These data are indicative of a highly significant correlation (r=0.81, P=0.03) between potency against 5-HT-induced contraction and that against contractile response to K+ depolarization, and suggest overlap of the pharmacology of L-type Ca2+-channel blockers and 5-HT2 receptor antagonists in rat aorta.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Cyproheptadine hydrochloride
CAS:41354-29-4 |
C21H21N.3/2H2O.HCl |
|
Developing structure-activity relationships for the predicti...
2010-07-19 [Chem. Res. Toxicol. 23 , 1215-22, (2010)] |
|
A predictive ligand-based Bayesian model for human drug-indu...
2010-12-01 [Drug Metab. Dispos. 38 , 2302-8, (2010)] |
|
Chemical genetics reveals a complex functional ground state ...
2007-05-01 [Nat. Chem. Biol. 3(5) , 268-273, (2007)] |
|
Genetic mapping of targets mediating differential chemical p...
2009-10-01 [Nat. Chem. Biol. 5 , 765-71, (2009)] |
|
Development and validation of an ultra-performance liquid ch...
2015-03-01 [Biomed. Chromatogr. 29(3) , 465-74, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
